OS Therapies, Inc. (NYSE-A: OSTX) entered into agreements for the commercial manufacture of OST-HER2. The company is ...
New York Post on MSN16d
I had a one-in-a-million tumor eating my bones — the signs that made me beg doctors to see meAshley Christine, 37, knew something was seriously wrong, but she was met with a lack of urgency as she tried to schedule an ...
Long-term survival rates for bone cancers - such as osteosarcoma and Ewing sarcoma - haven't changed in over 15 years, new research by the University of Nottingham shows. Fewer than seven in 10 ...
Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...
New research using data from the 100,000 Genomes Project has identified a genetic change that drives osteosarcoma, an ...
Bone sarcomas in adolescents and young adults (AYA) inclusive of osteosarcoma (OGS) and Ewing sarcoma (ES) are rare, aggressive yet chemotherapy-sensitive tumors with variable survival rates in low- ...
Professor Anamika Prasad from Florida International University developed 3D-printed implants in the form of scaffold ...
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback